MassMutual Private Wealth & Trust’s Collegium Pharmaceutical COLL Stock Holding History

MassMutual Private Wealth & Trust’s Portfolio COLL Stock Details COLL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$10.3K	Hold	285	–	–	﹤0.01%	1400
2026 Q1	$9.43K	Hold	285	–	–	﹤0.01%	1392
2025 Q4	$13.2K	Sell	285 -5	-2%	-$209	﹤0.01%	1279
2025 Q3	$10.1K	Hold	290	–	–	﹤0.01%	1396
2025 Q2	$8.57K	Buy	290 +83	+40%	+$2.37K	﹤0.01%	1421
2025 Q1	$6.18K	Buy	207 +136	+192%	+$4.16K	﹤0.01%	1503
2024 Q4	$2.03K	Hold	71	–	–	﹤0.01%	1834
2024 Q3	$2.74K	Hold	71	–	–	﹤0.01%	1563
2024 Q2	$2.29K	Hold	71	–	–	﹤0.01%	1585
2024 Q1	$2.76K	Hold	71	–	–	﹤0.01%	1447
2023 Q4	$2.19K	Buy	+71	New	+$1.78K	﹤0.01%	1474
2022 Q2	–	Sell	-79	Closed	-$2K	–	1550
2022 Q1	$2K	Buy	79 +48	+155%	+$907	﹤0.01%	1136
2021 Q4	$1K	Buy	+31	New	+$604	﹤0.01%	1193

Other funds holding COLL

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

PCM

Peregrine Capital Management Minneapolis, Minnesota $3.08B AUM 29.51% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $424B AUM 22.94% 1-Year Est. Return

SGAM

Smith Group Asset Management Dallas, Texas $2.46B AUM 57.16% 1-Year Est. Return

WCM

Wedge Capital Management Charlotte, North Carolina $6.06B AUM 47.24% 1-Year Est. Return

AIM

Artemis Investment Management Edinburgh, United Kingdom $11.2B AUM 80.72% 1-Year Est. Return

ETC

Exchange Traded Concepts Oklahoma City, Oklahoma $21.9B AUM 68.6% 1-Year Est. Return

Eastern Bank Boston, Massachusetts $6.53B AUM 30.05% 1-Year Est. Return

EIP

Easterly Investment Partners Beverly, Massachusetts $1.97B AUM 25.87% 1-Year Est. Return

MassMutual Private Wealth & Trust's COLL Position: Q2 2026 in Review

MassMutual Private Wealth & Trust held its Collegium Pharmaceutical (COLL) position steady in Q2 2026 at 285 shares worth $10.3K. The position accounts for ﹤0.01% of the portfolio, ranked #1400.

MassMutual Private Wealth & Trust first reported a position in COLL in Q4 2021 and has held it in 13 quarters since. The position peaked at $13.2K in Q4 2025. 66 funds tracked by Wall St. Rank hold COLL as of Q2 2026.

MassMutual Private Wealth & Trust held 285 shares of Collegium Pharmaceutical worth $10.3K as of Q2 2026.
MassMutual Private Wealth & Trust left its Collegium Pharmaceutical share count unchanged in Q2 2026.
Collegium Pharmaceutical made up ﹤0.01% of MassMutual Private Wealth & Trust's portfolio in Q2 2026, its #1400 holding.
MassMutual Private Wealth & Trust first reported a position in Collegium Pharmaceutical in Q4 2021 and has held it in 13 quarters since.
MassMutual Private Wealth & Trust's Collegium Pharmaceutical position peaked at $13.2K in Q4 2025.
66 funds tracked by Wall St. Rank held Collegium Pharmaceutical as of Q2 2026.

Based on MassMutual Private Wealth & Trust's 13F filing for Q2 2026, filed 2 Jul 2026.